CADD

Argenta's CADD group comprises highly experienced molecular modellers and is directed by Dr David Clark. The group offers the full complement of CADD capabilities such as ligand- and structure-based drug design, protein modelling and QSAR, including predictive/in silico ADMET. We utilise a comprehensive range of industry standard software combined with computational approaches developed in-house.

For more information on our CADD capabilities please contact us.